These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8959084

  • 1. Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy.
    Jenkins PJ, Jain A, Jones SL, Besser GM, Grossman AB.
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):447-51. PubMed ID: 8959084
    [Abstract] [Full Text] [Related]

  • 2. The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine.
    Grossman A, Wass JA, Besser M.
    Acta Endocrinol (Copenh); 1987 Oct; 116(2):275-81. PubMed ID: 3661064
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of a new long-acting injectable form of bromocriptine in hyperprolactinaemic patients.
    Pagani MD, Tengattini F, Montini M, Pagani G, Pedroncelli A, Gianola D, Gherardi F, Mazzocchi N, Cortesi L, Lancranjan I.
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):369-74. PubMed ID: 1424170
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Parenteral, depot and repeatable forms of Parlodel LAR bromocriptine in the treatment of hyperprolactinemia syndrome. Comparison with oral Parlodel].
    Dolecek R, Lancranjanová I, Putz Z, Vavros D, Závada M.
    Cas Lek Cesk; 1993 Feb 15; 132(3):81-5. PubMed ID: 8458069
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Positive response to compound CV 205-502 in hyperprolactinemic patients resistant to or intolerant of bromocriptine.
    Merola B, Sarnacchiaro F, Colao A, Di Somma C, Di Sarno A, Ferone D, Selleri A, Landi ML, Schettini G, Nappi C.
    Gynecol Endocrinol; 1994 Sep 15; 8(3):175-81. PubMed ID: 7847102
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. New long-acting bromocriptine (Parlodel MR and Parlodel LAR) in the treatment of pituitary tumours with hyperprolactinemia.
    Zgliczyński W, Zgliczyński S, Makowska A, Słowinska-Srzednicka J, Janik J, Jeske W, Walecki J.
    Endokrynol Pol; 1992 Sep 15; 43(3):234-41. PubMed ID: 1345564
    [Abstract] [Full Text] [Related]

  • 14. Domperidone antagonizes bromoergocriptine--induced nausea and vomiting without affecting its inhibition of prolactin secretion in puerperal women.
    Nappi C, Colace G, Di Renzo GF, Taglialatela M, Amoroso S, Annunziato L, Montemagno U.
    Eur J Clin Pharmacol; 1987 Sep 15; 32(5):457-60. PubMed ID: 3622595
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of vaginal bromocriptine in treating women with hyperprolactinemia.
    Kletzky OA, Vermesh M.
    Fertil Steril; 1989 Feb 15; 51(2):269-72. PubMed ID: 2912773
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Double blind randomized study using oral or injectable bromocriptine in patients with hyperprolactinaemia.
    Ciccarelli E, Grottoli S, Miola C, Avataneo T, Lancranjan I, Camanni F.
    Clin Endocrinol (Oxf); 1994 Feb 15; 40(2):193-8. PubMed ID: 8137517
    [Abstract] [Full Text] [Related]

  • 18. Long term therapy of patients with macroprolactinoma using repeatable injectable bromocriptine.
    Ciccarelli E, Miola C, Grottoli S, Avataneo T, Lancranjan I, Camanni F.
    J Clin Endocrinol Metab; 1993 Feb 15; 76(2):484-8. PubMed ID: 8432794
    [Abstract] [Full Text] [Related]

  • 19. Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemia.
    Ciccarelli E, Ghigo E, Mazza E, Andreis M, Massara F, Lancranjan I, Camanni F.
    J Endocrinol Invest; 1987 Apr 15; 10(2):179-82. PubMed ID: 3584856
    [Abstract] [Full Text] [Related]

  • 20. Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia.
    Ciccarelli E, Miola C, Avataneo T, Camanni F, Besser GM, Grossman A.
    Fertil Steril; 1989 Dec 15; 52(6):930-5. PubMed ID: 2591571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.